TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest

Trial Profile

TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs TR 987 (Primary)
  • Indications Varicose ulcer; Wounds
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2017 Status changed from recruiting to completed.
    • 17 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top